Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Multiple myeloma can arise when plasma cells transform into malignant plasma cells which leads to the uncontrolled growth of these abnormal plasma cells.

These tumors destroy intricate bone ... is considered the earliest precursor of multiple myeloma, before symptoms are present ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of ... In MinimuMM-seq, we examine circulating tumor cells (CTC) derived from patient blood samples.

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

Multiple myeloma is cancer of the bone marrow; the “multiple” part refers to cancer cells that appear in various areas of the body as cancerous plasma cells overtake ... not necessarily fully ...

1 Multiple myeloma originates in blood plasma ... She also served as a co-chair for the Plasma Cell Disorders and Adult Solid Tumors Working Committee at the Center for International Blood ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

Myeloma is a cancerous disorder of plasma cells that occurs primarily in patients in their forties and fifties, though younger patients are also at risk. The disease causes anemia, bone ...

The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...